Advertising Botox in the UK: What You Can Say

An aesthetic clinic posts a before and after photo from a Botox treatment on Instagram, captions it with a January offer on two areas, tags the nurse who performed it, and adds #botox at the end. That single post contains four separate breaches of the advertising rules, and the clinic almost certainly believed it was doing nothing unusual. Botox is a prescription-only medicine, and posts like it appear in every UK aesthetics feed, which is exactly why the Advertising Standards Authority now monitors the category actively rather than waiting for complaints.

Why advertising Botox UK rules are stricter than most clinics expect

Botulinum toxin is a prescription-only medicine. Part 14 of the Human Medicines Regulations 2012 prohibits advertising any prescription-only medicine to the public, and the Medicines and Healthcare products Regulatory Agency treats breaches as a criminal matter rather than a marketing infraction. Rule 12.12 of the CAP Code mirrors that prohibition and is enforced by the ASA.

Three points catch practitioners out repeatedly.

The prohibition applies regardless of who is advertising. A GMC-registered doctor posting about toxin on their own clinic account is in the same position as a beauty salon. Professional registration is not a defence, and in some respects it raises the stakes, because rule 12.18 separately bars health professionals from endorsing a prescription-only medicine.

It applies to every brand. Botox, Dysport, Azzalure, Bocouture and any other botulinum toxin product are all covered. Dermal fillers are not, because they are devices rather than medicines, which is the source of most of the confusion in mixed treatment menus.

And it applies to every medium. Leaflets, price lists, posters, websites, paid search, organic social posts, stories and hashtags are all advertising. Owned channels are not exempt from the rules simply because no money changed hands.

What ASA Botox rulings show about where the line falls

The published rulings are more useful than the code text, because they show how far the indirect prohibition reaches.

Direct references are the obvious breach. Indirect references are where clinics lose. Invented brand names such as Beautox breach the rules where the inference is obvious. Phrases like “wrinkle relaxing injections” are treated as indirect promotion because they can only mean one thing. In December 2024 the ASA upheld a complaint against a company promoting “cosmetic injections”, because it had listed that category separately from dermal fillers and lip fillers and the promotion applied only to anti-wrinkle injections, which made it an indirect ad for a prescription-only medicine.

Before and after photographs are treated as efficacy claims and are not permitted, which surprises practitioners more than any other rule, since results photography is the backbone of most aesthetic marketing.

Celebrity and health professional endorsement is a separate breach under rule 12.18. In 2023 the ASA ruled against ads on a reality television star’s Instagram Stories on both counts at once.

Social responsibility applies on top of everything else. A 2023 ruling against a “Back to School Botox” campaign found that the ads exploited women’s insecurities about ageing, which would have been a breach even if the product had not been named. The full ASA guidance on advertising botulinum toxin products sets out each of these with the underlying rulings.

Advertising botox on social media: the traps that catch compliant clinics

CAP issued an enforcement notice specifically on social media and has run compliance monitoring since. Several traps are peculiar to the channel.

• Hashtags count as part of the ad. A caption written carefully and then tagged #botox has undone itself in the final line.
• Reposting transfers responsibility. Sharing a patient’s story, a supplier’s post or another clinic’s content makes the reposting business responsible for that content under UK rules.
• Patient content is still advertising. A tagged review, a repost of a client’s selfie, or a testimonial naming the treatment all promote the medicine, whoever wrote it originally.
• Competitions and packages count. Offering toxin as a prize or bundling it into a promotional package is promotion.
• Account names and bios count. A handle or business name built around a toxin reference carries the breach into every post.

Influencer arrangements are advertising by definition, and gifted treatment in exchange for coverage sits squarely inside both the POM prohibition and the endorsement rule. Clinics building visibility should read the ASA enforcement notice on Botox advertising on social media before briefing anyone. Practitioners rethinking their content strategy may also find how to build a £5K a month aesthetics business useful for the channels that are not restricted.

The consultation exception and how to use it correctly

There is a narrow exception, and it applies to websites only.

Clinic and pharmacy websites offering consultations for the treatment of lines and wrinkles may provide information about a prescription-only medicine, but only in the context of it being one possible treatment option following a consultation. A claim such as “a consultation for the treatment of lines and wrinkles” is likely to be acceptable. The product name must not appear in the initial ad.

The practical conditions matter more than the principle. No reference to the medicine should appear in sponsored ads, on the homepage, in logos, in testimonials, in hover text, or in footer small print that links straight to a page where it is named. The ASA’s test is whether a casually browsing consumer would come across the information with ease. If a visitor can reach product details in one click from the homepage, the exception does not protect the site.

Content sitting inside the exception must also be balanced and factual, in line with the patient information leaflet and the Summary of Product Characteristics. That rules out claims about treatment areas the product is not licensed for. Price lists may include a range of treatments, but they must not carry product claims or invite people to choose based on price, and pairing a price with “anti-wrinkle injections” has been treated as an ad for the medicine.

One further point from the ASA’s Botox FAQs: a clinic offering only prescription treatments should avoid “anti-wrinkle injections” entirely. The same phrase is likely to be acceptable for a business that offers only non-POM treatments and never administers toxin at all. The phrase is not the issue. What it can only refer to is.

MHRA Botox advertising enforcement and what actually happens

Two bodies sit behind this, and they escalate to each other.

The ASA handles complaints and compliance. Its sanctions include published rulings naming the business, removal of paid search ads, placement on the list of non-compliant online advertisers, and referral to Trading Standards. Where advertisers will not comply, the ASA refers cases to the MHRA and to relevant professional regulators.

The MHRA Advertising Standards Unit handles the statutory side, where the prohibition carries criminal liability rather than reputational consequences alone.

The third route is the professional regulator. A referral to the GMC, NMC, GDC or GPhC turns an advertising problem into a fitness to practise question, and that is the outcome with the longest tail. Indemnity providers also ask about regulatory findings at renewal.

Clinics wanting a check before publishing can use the free CAP Copy Advice service for non-broadcast advertising, which reviews wording in advance at no cost.

What compliant clinic marketing looks like instead

The channel is not closed. It changes shape.

Promote the consultation rather than the treatment. “Book a consultation for the treatment of lines and wrinkles” is compliant, and it converts, because a consultation is what the patient needs first anyway.

Promote what is not restricted. Dermal fillers, skin boosters, peels, microneedling and skincare can be advertised on their merits, using “cosmetic fillers” or “injected fillers” where injectables are involved. Claims for those still need substantiation, as the regulatory reality of glutathione injections and what is legal and what is hype with exosomes both illustrate.

Promote the practice rather than the product. Practitioner registration and qualifications, complication protocols, aftercare, the consultation process and the clinic environment are all fair game and are what patients weigh anyway. A verified profile in a clinic directory for aesthetic practitioners does that work without touching the restricted category, and platform pages showcase your treatments within the same framework.

Botox advertising to healthcare professionals sits under a different rule

Rule 12.12 permits advertising prescription-only medicines directly to the medical, dental, veterinary and allied professions. That exemption is why B2B aesthetics platforms gate pricing behind a verified login rather than publishing it openly, and it is a legal requirement rather than a commercial choice.

Understanding the product itself helps with compliant copy, because the balanced and factual requirement is tied to the licence. Botox is onabotulinumtoxinA, which blocks acetylcholine release at the neuromuscular junction and temporarily relaxes the injected muscle. Its UK cosmetic licence covers glabellar lines, lateral canthal lines and forehead lines in adults, with separate therapeutic licences including severe primary axillary hyperhidrosis. Onset runs from three to seven days, peak effect at around two weeks, and duration of three to four months. Anything written about areas outside that licence falls outside what the exception permits.

Vial sizing is a stock decision. Botox 50 Units suits lower-volume lists where reconstituted product would otherwise be wasted, since it should be stored at 2 to 8 degrees Celsius and used within 24 hours of reconstitution with preservative-free sodium chloride. Botox 100 Units is the standard aesthetic presentation. Botox 200 Units is generally reserved for higher-dose therapeutic use. Units are brand-specific and are not interchangeable across toxin brands, which matters for internal protocols as much as for anything published.

Market Your Clinic Without Breaching the Rules

Build visibility through a verified Faces clinic profile that promotes your consultations, qualifications and non-restricted treatments without touching prescription-only advertising rules. If a compliance sweep has just stripped a chunk of content from your social accounts, this is where that effort is better spent. A Faces profile built around your consultation process and your qualifications does not need rewriting every time the guidance is updated. List your aesthetic clinic on Faces now.

FAQs